Pharma major Lupin Limited has secured exclusive marketing rights for the gastroenterology brand Plasil in the Philippines and Brazil. Subsidiaries in these nations inked a deal with Italy's Neopharmed Gentili S.p.A. This move will boost Lupin's gastroenterology offerings and market reach. Plasil treats nausea, vomiting, and motility disorders.
You will be redirected in 10 seconds.